Norovirus, Astrovirus, and Sapovirus among immunocompromised patients at a tertiary care research hospital

We estimated the prevalence of astrovirus, sapovirus, and norovirus among patients enrolled in research protocols and receiving medical care at the Clinical Center of the National Institutes of Health, Bethesda, MD, a clinical research hospital with a large immunocompromised patient population. We identified patients whose fecal specimens were submitted to the Clinical Center for testing on the Biofire FilmArray Gastrointestinal Panel from Sept 15, 2015 through Nov 30, 2016. Among 442 patients with fecal specimens submitted for multiplex testing, 11% had norovirus identified, 2% had astrovirus, and 2% had sapovirus.
Source: Diagnostic Microbiology and Infectious Disease - Category: Microbiology Authors: Source Type: research